HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $23,701 | +3692.2% | 343,417 | +4574.9% | 0.06% | +1933.3% |
| Q2 2023 | $625 | +2.8% | 7,346 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $608 | +5.2% | 7,346 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $578 | -99.9% | 7,346 | 0.0% | 0.00% | 0.0% |
| Q3 2022 | $544,000 | +13.6% | 7,346 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $479,000 | +3.2% | 7,346 | 0.0% | 0.00% | +50.0% |
| Q1 2022 | $464,000 | +19.0% | 7,346 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $390,000 | -24.9% | 7,346 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $519,000 | +5.9% | 7,346 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $490,000 | -98.0% | 7,346 | -96.7% | 0.00% | -98.3% |
| Q1 2021 | $24,891,000 | -6.6% | 224,226 | -0.1% | 0.12% | -10.1% |
| Q4 2020 | $26,657,000 | +35.7% | 224,477 | -0.3% | 0.13% | +24.0% |
| Q3 2020 | $19,649,000 | -6.7% | 225,208 | -4.2% | 0.10% | -13.3% |
| Q2 2020 | $21,056,000 | +4.2% | 235,103 | +16.0% | 0.12% | -14.9% |
| Q1 2020 | $20,198,000 | +25.0% | 202,669 | +44.1% | 0.14% | +54.9% |
| Q4 2019 | $16,160,000 | +47.9% | 140,641 | +62.3% | 0.09% | +35.8% |
| Q3 2019 | $10,928,000 | +1050.3% | 86,631 | +997.6% | 0.07% | +1016.7% |
| Q2 2019 | $950,000 | +22.3% | 7,893 | -11.2% | 0.01% | +20.0% |
| Q1 2019 | $777,000 | -12.6% | 8,886 | 0.0% | 0.01% | -16.7% |
| Q4 2018 | $889,000 | -12.7% | 8,886 | 0.0% | 0.01% | 0.0% |
| Q3 2018 | $1,018,000 | +27.7% | 8,886 | 0.0% | 0.01% | +20.0% |
| Q2 2018 | $797,000 | +22.6% | 8,886 | 0.0% | 0.01% | +25.0% |
| Q1 2018 | $650,000 | +21.5% | 8,886 | -3.6% | 0.00% | +33.3% |
| Q4 2017 | $535,000 | +29.5% | 9,214 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $413,000 | +13.5% | 9,214 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $364,000 | -2.7% | 9,214 | 0.0% | 0.00% | 0.0% |
| Q1 2017 | $374,000 | +1.1% | 9,214 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $370,000 | +10.8% | 9,214 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $334,000 | +9.9% | 9,214 | -12.0% | 0.00% | 0.0% |
| Q2 2016 | $304,000 | -16.9% | 10,474 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $366,000 | +22.8% | 10,474 | +13.2% | 0.00% | 0.0% |
| Q4 2015 | $298,000 | -0.3% | 9,251 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $299,000 | -21.9% | 9,251 | 0.0% | 0.00% | 0.0% |
| Q2 2015 | $383,000 | -7.9% | 9,251 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $416,000 | +20.2% | 9,251 | 0.0% | 0.00% | 0.0% |
| Q4 2014 | $346,000 | +7.1% | 9,251 | 0.0% | 0.00% | 0.0% |
| Q3 2014 | $323,000 | -0.9% | 9,251 | 0.0% | 0.00% | 0.0% |
| Q2 2014 | $326,000 | +213.5% | 9,251 | +189.1% | 0.00% | +200.0% |
| Q1 2014 | $104,000 | -23.0% | 3,200 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $135,000 | -98.3% | 3,200 | -98.4% | 0.00% | -98.6% |
| Q3 2013 | $8,056,000 | -6.1% | 202,000 | -2.7% | 0.07% | -8.6% |
| Q2 2013 | $8,580,000 | – | 207,500 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |